Samsung Announces Move into Biomedical Business

Feb. 25, 2011
Will produce drugs for cancer and arthritis patients at biopharmaceutical plant in Seoul

Samsung will invest $266 million in a pharmaceutical joint venture, as part of a ten-year multi-billion dollar attempt to develop new growth engines.

Samsung said work would start in the first half of this year on a biopharmaceutical production plant at Songdo International City, part of the Incheon Free Economic Zone west of Seoul.It said that production of drugs for cancer and arthritis patients was expected to start in the first half of 2013.

Samsung Electronics and Samsung Everland would each own 40% of the joint venture, Samsung C and T would have 10% and U.S.-based pharmaceutical multinational Quintiles would own the remaining 10%.

Samsung, which accounts for 20% of the country's exports, in May last year announced plans to invest 23 trillion won in healthcare and green energy over the next decade. Some 2.1 trillion of the total was earmarked for biopharmaceuticals and today's announcement signaled the first major step in those plans.

Samsung said it would initially be engaged in contract manufacturing but planned in the longer term to develop its own products.

Copyright Agence France-Presse, 2011

See Also
Samsung Investing $38.3 Billion in 2011 to Get Ahead of Rivals

Popular Sponsored Recommendations

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Modern Edge Computing Accelerates Smart Manufacturing Initiatives for Discrete Manufacturers

Oct. 22, 2023
Discover how Edge Computing platforms are a requisite for discrete manufacturers to solve production challenges, accelerate digitalization, and establish a reliable infrastructure...

How Digital Twin Technology is Empowering Manufacturers

Sept. 27, 2023
This FAQ delves into why this technology offers business value and considerations toward implementation.

Process Mining For Dummies

Nov. 19, 2023
Here it is. Everything you need to know about process mining in a single book, written in the easy-to-understand, hard-to-forget style that ‘For Dummies’ manages so effortlessly...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!